BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 10829314)

  • 21. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
    Ausch C; Rosen HR; Schiessel R
    Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
    Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
    Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stage-adapted radical principles in gastric carcinoma].
    Verreet PR
    Praxis (Bern 1994); 1998 Mar; 87(13):447-50. PubMed ID: 9584570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neoadjuvant chemotherapy in gastric carcinoma].
    D'Ugo D; Persiani R; Pende V; Picciocchi A
    Ann Ital Chir; 2001; 72(1):47-53. PubMed ID: 11464495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
    Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
    Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
    Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
    J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of irradiation as a component of combined modality treatment for gastric cancer.
    Gunderson LL; Burch PA; Donohue JH
    J Infus Chemother; 1995; 5(3):117-24. PubMed ID: 8528968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of radiation therapy in gastric cancer.
    Willett CG
    Semin Radiat Oncol; 2002 Apr; 12(2):170-5. PubMed ID: 11979418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma.
    Klautke G; Foitzik T; Ludwig K; Ketterer P; Klar E; Fietkau R
    Strahlenther Onkol; 2004 Nov; 180(11):695-700. PubMed ID: 15549187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypothetical and reliable aspects of pre-, intra- and postoperative adjuvant therapy of stomach carcinoma].
    Meyer HJ; Opitz GJ; Jähne J; Wilke H
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():312-7. PubMed ID: 9931631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy in gastric cancer.
    Lim L; Michael M; Mann GB; Leong T
    J Clin Oncol; 2005 Sep; 23(25):6220-32. PubMed ID: 16135489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal therapy of gastric cancer.
    Mlkvý P
    Dig Dis; 2010; 28(4-5):615-8. PubMed ID: 21088412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined-modality therapy for gastric cancer.
    Yao JC; Mansfield PF; Pisters PW; Feig BW; Janjan NA; Crane C; Ajani JA
    Semin Surg Oncol; 2003; 21(4):223-7. PubMed ID: 14648779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.